Novo Nordisk Articles
Novo Nordisk submits US NDA for GLP-1
2 June 2008
Medarex to get Novo Nordisk milestone
7 April 2008
Pieris raises 25M euros in financing round
31 March 2008
Stock Commentary - New York week to March 24, 2008
31 March 2008
Drug industry in 2020, at Economist
17 March 2008
Affimed increases series B financing round to 30M euros
25 February 2008
Novo Nordisk names Pamela Harris as VP of diabetes sales
25 February 2008
Nordisk signs French blood clot drug accord
18 February 2008
Novo Nordisk's 2007 EPS beats expectations
11 February 2008
Genmab jumped share jump 5% on takeover rumors
4 February 2008
Novo Nordisk hires Alan Moses
14 January 2008
Novo Nordisk licenses preclinical hemophilia candidate
24 December 2007
Novo Nordisk settles law suit with Pfizer over Exubera
17 December 2007
Novo Nordisk launches Changing Diabetes Barometer
17 December 2007
Liraglutide cuts weight in obese non-diabetics
26 November 2007
Nordisk and Sciele sign marketing deal
26 November 2007
Novo Nordisk supports diabetes documentary
19 November 2007
"Medicon Valley" cluster emerges in Denmark
19 November 2007
Novo Nordisk's nine-month profit soars 60%
12 November 2007
Japan's MHLW clears Novo Nordisk's Levemir
29 October 2007
Nordisk's NovoRapid gains EC clearance
1 October 2007
Lack of HbA1c testing increasing risk to diabetes sufferers
1 October 2007
Large HbA1c reduction with Novo's liraglutide
24 September 2007
Liraglutide impresses in Ph III trials
3 September 2007
Millipore to distribute Novo's insulin for cell culture
3 September 2007
Novo Nordisk's 2nd-qtr net profit soars 112%
13 August 2007
WDF summit sponsor keeps a low profile
9 July 2007
Novo Nordisk to open $100M plant in NC, USA
2 July 2007
Liraglutide impresses in Ph II study
2 July 2007
Liraglutide gives better control than Lantus
2 July 2007
Novo Nordisk inaugurates new 350M kroner pilot plant
18 June 2007
Norditropin gets FDA OK for Noonan syndrome
18 June 2007
Neose gets milestone on Factor IX program
4 June 2007
Novo Nordisk's 1st-qtr 2007 profit rises 41%
14 May 2007
Novo Nordisk opens Brazil insulin plant
7 May 2007
No weight gain for "majority" on Levemir
16 April 2007
Novo Nordisk growing in Japan
19 March 2007
Novo/CAS set up China research foundation
12 March 2007
Stock Commentary - Europe - week to Feb 26, 2007
5 March 2007
NovoSeven misses Ph III trial primary endpoint
5 March 2007
Novo Nordisk US hires Henrik Rasmussen
26 February 2007
Novo's full-year 2006 net profit rises 10%
12 February 2007
Levemir demonstrates safety and efficacy
7 February 2007
Novo Nordisk refocuses R&D
22 January 2007
EFPIA Japan elects new board members
15 January 2007
Novo's motion to block US Exubera denied
22 December 2006
Daily NovoSeven cuts bleed frequency 45%
22 December 2006
Encouraging weight loss findings for Levemir
18 December 2006
NovoMix 30 aids long-term glucose control
18 December 2006
Novo Nordisk boosts US sales force
11 December 2006
Novo Nordisk milestone for Neose
4 December 2006
Mixed results for Novo Nordisk in 3rd-qtr 2006
6 November 2006
Joe Young joins Amylin as senior VP marketing
9 October 2006
Novo Nordisk's liraglutide improves insulin secetion
25 September 2006
Aradigm granted continued Nasdaq listing
4 September 2006
Novo milestone for Neose Technologies
14 August 2006
Pfizer sued by Novo for patent infringement
7 August 2006
Novo Nordisk's 1st-half 2006 sales rise 20%
7 August 2006
NovoRapid gets EC OK for pregnant diabetics
7 August 2006
Xencor raises $6.0 million in combined financing
17 July 2006
Neose identifies proteins for Novo Nordisk deal
10 July 2006
Sanofi's OptiClick pen under US ITC scrutiny
19 June 2006
Senior appointments at Nova Nordisk
22 May 2006
Novo Nordisk's 1st-qtr 2006 sales up 23%
15 May 2006
Michael Dwyer joins ZymoGenetics
1 May 2006
Denmark investigates Novo Nordisk
3 April 2006
EMEA expands label on Novo Nordisk's NovoMix 30
27 March 2006
NovoNordisk pays $69M to Argos for SLE MAb
27 March 2006
Nastech enters R&D accord with Novo Nordisk
20 March 2006
US SEC investigates Novo's oil-for-food program
27 February 2006
Novo milestone for Neose
20 February 2006
Novo Nordisk sees a 16% climb in profits
6 February 2006
Insulin detemir limits diabetic weight gain
19 September 2005
Novo Nordisk restructures R&D
22 August 2005
Novo Nordisk's first-half sales rise 15%
22 August 2005
Novo Nordisk debuts GlucaGen HypoKit
18 July 2005
Innate attains milestone in Novo deal
27 June 2005
Novo's Levemir Ok'd in USA for diabetes
27 June 2005
FDA approves Levemir
27 June 2005
A-Bio/Novo Nordisk sign Master Service Agreement
6 June 2005
Neose gets milestone from Novo Nordisk
23 May 2005
Novo Nordisk sales up 11%, EPS rises 19%
16 May 2005
US volume Rx sales rise 8.3% in 2004
21 February 2005
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
